The TrxR1 has emerged as an important target in cancer chemo-therapy, due to its overexpression in a variety of human cancer types (i.e. breast, gastric) and association with increased tumor growth, drug resistance and poor patient prognosis. The gene discussed is TXNRD1; the disease is cancer.